The aim of the Transplant Complications Working Party is to conduct research as well as provide education and expertise on the subject of non-infectious complications after hematopoietic cell transplantation. The major fields of interest of the TCWP are:
- Early complications e.g. graft failure, VOD/SOS, transplant-associated microangiopathy (TAM), other endothelial syndromes, impact of co-morbidities, toxicity of conditioning regimen and supportive care;
- Acute and chronic graft versus host disease – all the aspects from risk factors through diagnosis to treatment;
- Late effects – e.g. infertility, sexual dysfunction, secondary cancers, organ-specific late complications, quality of life.
The TCWP is a transversal Working Party, covering complications occurring after transplantation for all the indications. Therefore, its performance is strictly related to collaboration with disease-specific working parties, and studies directly dedicated to non-infectious complications should be performed either in or in close collaboration with TCWP.
To submit a proposal to the TCWP for a new study, download the following documents:
Guidelines, Consensus Statements, and Position Papers
Open calls to participate in a new study
The Transplant Complications Working Party is currently overseeing the following studies.
SFAST: A cross-sectional study on the sexual function of adult survivors and their partners 3 and 15 years post allogeneic stem cell transplantation
PI: Corien Eeltink
Complications of haploidentical HCT with post-transplant cyclophosphamide - a non-interventional prospective study
PI: Grzegorz Basak
NIS: EASIX to predict alloSCT outcome
PIs: Olaf Penack and Thomas Luft
Fecal microbiota transplantation in the treatment of graft-versus-host disease – retrospective survey
PI: Jarosław Biliński
Current practice in vitamin D assessment and management across the Adult and Paediatric Haematopoietic Stem Cell Transplant Centres in Europe (SUNSHINE).
PI: Jose Ros-Soto
Late effects after hematopoietic stem cell transplantation in patients with HLH.
PI: Anna Carin-Horne